Blog of the Society for Menstrual Cycle Research

Hold the Eggs When Ovulating

August 11th, 2010 by Elizabeth Kissling

Fascinating new research from the National Institutes of Health finds that women’s cholesterol levels correspond with cyclic changes in estrogen levels. Total cholesterol levels can vary by as much as 19% over the course of the cycle.

The researchers found that as the level of estrogen rises, high-density lipoprotein (HDL) cholesterol also rises, peaking at the time of ovulation.

In a typical cycle, estrogen levels steadily increase as the egg cell matures, peaking just before ovulation. Previous studies have shown that taking formulations which contain estrogen — oral contraceptives or menopausal hormone therapy — can affect cholesterol levels. However, the results of studies examining the effects of naturally occurring hormone levels on cholesterol have not been conclusive. According to the NIH’s National Heart, Lung and Blood Institute, high blood cholesterol levels raise the risk for heart disease.

. . . .


In contrast, total cholesterol and low-density lipoprotein (LDL) cholesterol levels — as well as another form of blood fat known as triglycerides — declined as estrogen levels rose. The decline was not immediate, beginning a couple of days after the estrogen peak at ovulation.

These findings provide another reason for girls and women to learn to track their cycles, so their blood tests can be interpreted more precisely.

It also gives more weight to the frequent assertion of members of the Society for Menstrual Cycle Research that menstruation matters — and is worthy of our study — in part because it is not an event isolated in the uterus and vagina, but a complex part of the endocrine system that has effects on health and well-being throughout a woman’s body.

Post to Twitter Post to Plurk Post to Yahoo Buzz Post to Delicious Post to Digg Post to Facebook Post to MySpace Post to Reddit Post to StumbleUpon

Hot Flash—Progesterone is an Effective Alternative to Estrogen

July 19th, 2010 by Elizabeth Kissling

Guest post by Jerilynn Prior, Centre for Menstrual Cycle and Ovulation Research

hot flash hellIt’s been two weeks since Chris Hitchcock and I returned from San Diego’s recent Endocrine Society meetings. We are feeling incredibly happy with the success of our protracted, intense commitments to a controlled trial of oral micronized progesterone (marketed in the USA and Canada as Prometrium®) for night sweats and hot flushes/flashes. At the Endocrine Society we presented the first-ever trial showing that the molecularly identical progesterone by mouth is effective treatment for vasomotor symptoms (VMS = hot flushes/flashes and night sweats)(1). We were also invited to present our data at an Endocrine Society-sponsored press conference.

Why did a scientific study require so much from us? First, this trial started in 2003 as the initial scientific venture of the newly founded Centre for Menstrual Cycle and Ovulation Research–thus CeMCOR’s reputation became tied to this trial. Second, despite concerted efforts, we were never able to obtain peer reviewed funding for this study—we successfully supported it with individual private donations. Finally, because of the “estrogen myth” and its corollary negatives about progesterone, I wanted to gain additional accurate information about how Prometrium® works in women’s cardiovascular system from this same study. For that reason we decided to enroll only very healthy women who were within 1-10 years since their final flow—they had to be non-smokers, without obesity, diabetes, or high blood pressure, and further to have normal measured waist circumference, blood pressure, cholesterol, and fasting blood sugar levels. Therefore many women were interested but few were eligible.

Latest News on Hormone Therapy

June 23rd, 2010 by Elizabeth Kissling
Wellcome Library, London // CC 2.0

Wellcome Library, London // CC 2.0

The Endocrine Society has released a new, peer-reviewed statement on the risks and benefits of hormone therapy for menopausal women. The upshot is that risks and benefits vary depending on the age of the patient and the length of time since menopause:

One interesting finding . . . was that women who start hormone therapy within 10 years of menopause have a 30% to 40% reduction in total mortality.

In addition, in the 50 to 55 age group the task force concluded that hormone therapy reduced hot flashes and overactive bladder and that vaginal estrogen reduced recurrent urinary tract infections. The evidence also showed that hormone therapy reduced pain on intercourse and improved quality of life.

Given that there are thousands of lawsuits pending over the role of HT in breast cancer, I was especially interested in this nugget of new information:

“Our conclusion is that [the estrogen/progestin hormone combination] didn’t cause breast cancer — it caused preexisting tumors to grow to a size where they became detectable.”


Post to Twitter Post to Plurk Post to Yahoo Buzz Post to Delicious Post to Digg Post to Facebook Post to MySpace Post to Reddit Post to StumbleUpon

Early Menarche: A New Theory

June 13th, 2010 by Elizabeth Kissling
Photo by Splorp // CC 2.0

Photo by Splorp // CC 2.0

It’s well-documented that girls today reach menarche earlier than previous generations. A century ago, it was common to experience one’s first period at 16 or 17; today, that’s regarded as so late that medical examinations are often conducted to reassure parents and girls that their development is normal. The typical North American girl sees her first period at age 12, give or take a few months.

Many explanations have been posited for this phenomenon; personally, I’ve long suspected that a primary cause is endocrine disruptors that are the hormones used in raising beef and dairy cattle as well as chicken in this country. Also, girls today typically achieve the minimal body fat necessary to menstruate at younger ages, due to improved health and nutrition. Now a new study suggests that it is not merely consumption of meat that lowers the age of menarche, but the high content of zinc and iron in a meat-rich diet.

Oddly, the lead researcher is quoted in the news story as saying, “These results add to the evidence that it is healthiest to avoid diets containing very high amounts of meat,” but also that there is no need for young girls to cut their meat intake. (I haven’t yet been able to locate a copy of the actual study.)


Post to Twitter Post to Plurk Post to Yahoo Buzz Post to Delicious Post to Digg Post to Facebook Post to MySpace Post to Reddit Post to StumbleUpon

Are you ready?

May 29th, 2010 by Elizabeth Kissling

EvoPsych BINGOReady to play Evo-Psych bingo, that is. I don’t know quite what else to do with a study like this: Women’s preferences for masculinity in male faces are highest during reproductive age range and lower around puberty and post-menopause.

Post to Twitter Post to Plurk Post to Yahoo Buzz Post to Delicious Post to Digg Post to Facebook Post to MySpace Post to Reddit Post to StumbleUpon

Pill Protests – It’s About the Environment

May 25th, 2010 by Elizabeth Kissling
Empty birth control pill packet in the street

Photo by Gnarls Monkey // CC by 2.0

A whole bunch of anti-choice political organizations are co-sponsoring a national protest against birth control pills, but they say it’s not about killing babies or controlling women; it’s all about the environment!

The following is released by the American Life League and the following groups:

WHO: American Life League , Human Life International, Pro-Life Wisconsin, Pharmacists for Life International, Archdiocese of Mobile Respect Life, Operation Rescue, Jill Stanek, Generation Life/Brandi Swindell, Life Education Ministry, Pro-Life Unity, Movement for a Better America, AMEN (Abortion Must End Now), Pro-Life Action of Oregon, Children of God for Life, Expectant Mother Care/Chris Slattery, Mother and Unborn Baby Care, Defenders of the Unborn, California Right to Life Education Fund, Delaware Pro-Life Coalition, Life Guard, Homeschoolers for Life, Focus Pregnancy Center, Central Texas Voices for Life and Dubuque County Right to Life

WHAT: Protest the Pill Day 2010: The Pill Kills the Environment

This year, birth control advocates are celebrating 50 years of decriminalized hormonal contraceptives. American Life League and our co-sponsors don’t think half a century of contaminating our waterways is something to celebrate. Study after study has shown that hormonal estrogen in the water has severely damaged the ecosystem and our health.

Join American Life League and co-sponsors as they launch the largest nationwide protest against the birth control pill.

You know what, American Life League? ALL prescription drugs, not just birth control pills, contaminate our waterways, both through human excretion and production waste. And some of that “hormonal estrogen” is from the hormone supplements taken by middle-aged women. Are you protesting hormone “replacement” therapy, too?

[via Miriam at Feministing]

Post to Twitter Post to Plurk Post to Yahoo Buzz Post to Delicious Post to Digg Post to Facebook Post to MySpace Post to Reddit Post to StumbleUpon

Ultrasound Man:Birth Control Superhero

May 17th, 2010 by Laura Wershler

superheroYou know how most superheros become superheros because of exposure to some weird, intensified chemical or element? Take Peter Parker’s spider bite for example.

According to a story reported in various media, including International Planned Parenthood Federation’s website, if science can perfect the contraceptive effect of ultasound on men’s testicles, then we may be in for a new breed of superhero.  Ultrasound Man: able to bear the burden of pregnancy prevention for women everywhere. 

I joke, but for decades women have yearned for gender equality when it comes to bearing the burden of birth control. Could the promise of six months of ultrasound induced, reversible infertility in men be the answer? Well, to date, we only know it works in rats. There is a long way to go before we send the men for a bi-annual ultrasound “zap test”.

This isn’t the first male method touted over the last decade. In 2003, news out of the UK about a birth control pill for men had women nodding their heads with approval. I was immediately dubious and dashed off a commentary for the Calgary Herald that began thus:

Hooked on Estrogen

May 13th, 2010 by Elizabeth Kissling

Guest Post by Jerilynn Prior, M.D.,  Centre for Menstrual Cycle and Ovulation Research

Estrogen moleculeYes! I’m sure you can hear my whoop of excitement and vindication. Finally, something negative about estrogen and positive about progesterone in the mainstream media. According to this article by Emily Anthes in the current issue of Scientific American: Mind,  women’s risk for addiction, and potential for successful withdrawal, are both linked to our menstrual cycle hormones. Estrogen increases women’s addictive behaviors while progesterone assists with successful addiction recovery.

Why am I feeling vindicated? Because I recently declared that hot flushes/flashes and night sweats are estrogen addiction (1). That wild but supportable hypothesis is based on the evidence that prolonged or high-dose estrogen exposure is required for hot flushes to occur. But, it is the subsequent abrupt decrease in estrogen levels that triggers vasomotor symptoms. Drug exposure—drug withdrawal symptoms. And do women feel high on estrogen? Perhaps. Clearly the withdrawal is miserable—as one woman said, “I continued to take it only because I couldn’t stand being off the hormone. I really couldn’t function.” (p. 2130 (2). Just ask any woman taking estrogen for hot flushes who has tried to stop it.

Estrogen is the New Ritalin. NOT.

May 10th, 2010 by Elizabeth Kissling

Guest Post by Barbara Sommer, University of California-Davis

Ritalin bottle with tabletsWhy is it that assertions about hormones and behavior lead us to readily suspend our capacity for critical thought? It seems like folks will accept just about any assertion with regard to the power of estrogen and the fluctuation of the menstrual cycle.

My observations over several decades (I am nearly forty years post-doctorate) have been reassuring. I have not seen women crushed in the working and professional worlds by the demands of their physiology. In fact it looks like women might be moving towards running the world, at least in those areas where they have access to education. Nevertheless, it rankles when a journal of some credibility makes assertions based on scanty evidence.

It is difficult to evaluate the quality of the research underlying the claims of the article “Is Estrogen The New Ritalin?” in the current issue of Scientific American: Mind. The title is cute. A writer for the New Yorker recently claimed that “White is the New Black.” Do we believe it? The article was provocative, and did not pretend to be a scientific piece of work. In contrast, the estrogen piece, by appearing under the prestigious banner of the Scientific American, carries an imprint of scientific credibility. The first paragraph claims the menstrual cycle might affect the brain as much as caffeine, methamphetamines, and Ritalin. Nowhere in the study is there any indication that estrogen levels or even menstrual fluctuation effects were actually compared with the above substances. The author also claims that this study is “the first to show that cognition is tied to estrogen levels in people” – perhaps the first because no one else has done a good job of it, but certainly not for a failing to try. There are many published studies claiming that estrogen affects cognitive function.

The central problem with this report is that the scientific community has not vetted the research. There is nothing to suggest that it was subject to review. It has not been published – at least nowhere that could be found by this writer with access to a university library. I don’t expect a popular version of scientific research to include information about whether there were adequate controls for subject selection, for practice effects on the task performance, or that the claim of population dopamine levels was accurate, and whatever measure was used to estimate estrogen levels was reliable. But someone needs to have looked at those aspects of the research. Without that, we end up with questionable conclusions at best, and junk science at worst.

Post to Twitter Post to Plurk Post to Yahoo Buzz Post to Delicious Post to Digg Post to Facebook Post to MySpace Post to Reddit Post to StumbleUpon

Neurology and steroid hormones – where is progesterone in this discussion?

April 23rd, 2010 by Chris Hitchcock

Recently the New York Times published a long article entitled the Estrogen Dilemma. It’s an article rich with many issues, and previous blogs have critiqued its uncritical acceptance of the timing hypothesis, and its failure to distinguish between the transient symptoms of perimenopause, early menopause, and the rest of your long, healthy, post-menopausal life.

But it is quite remarkable to me that, when speculating about potential hormonal treatment for poor memory and issues of staying on task, the only steroid hormone that seemed to be on anyone’s radar was estrogen. The writer had a lot of space (7600 words) and gave the scientist a lot of freedom to speculate, so I’m guessing that the absence of progesterone in the article is a true representation of her conceptual blind-spot. Progesterone was mentioned a few times, in the context of protection from uterine cancer, and in the context of using MPA (a synthetic relative) as a possible scapegoat in interpreting the WHI randomized hormone therapy trial data. But never did I see any suggestion that progesterone might be anything other than a necessary evil.

In fact, there are some intriguing new research areas that look at progesterone as therapy in neurological domains.

Riddle me this: What’s wrong with birth control?

April 20th, 2010 by Laura Wershler

I read The Birth-Control Riddle by Melinda Beck, published today in The Wall Street Journal with interest and frustration.  As a veteran pro-choice sexual and reproductive health advocate, I’ve spent decades contemplating this ”riddle”. I have two specific comments in response to the piece, and a few suggestions for potential follow-up stories.
       birthcontrolmethods                                                                                                                                      
 1) I find it discouraging, but understandable, that the article failed even to mention fertility awareness based methods (FABM) of birth control, which when taught so that women/couples can use the method effectively and confidently have a 99.4% effectiveness rate. Don’t take my word for it. The German study called: The effectiveness of a fertility awareness based methods to avoid pregnancy in relation to a couple’s sexual behaviour during the fertile time: a prospective longitudinal study was published in the prestigious journal Human Reproduction in late 2007. 

In addition to the typical North American dismissiveness (by healthcare providers) of FABM as ineffective, is the dismissive response given to North American women who express an interest in learning FABM.  A quick google search or a week’s hits on a google news alert for “Fertility Awareness” (the secular, pro-choice variation of the religiously contextualized Natural Family Planning) quickly establishes the burgeoning interest and use of these methods by young American women. Why is this so readily ignored by the mainstream sexual and reproductive health community (of which I am a part)? I have been mulling over this question for years. I have arrived at several answers. How I would love to see a journalist, any journalist, start asking this question.

The Great Perimenopause Cover-Up

April 19th, 2010 by Elizabeth Kissling

Guest Post by Jerilynn C. Prior, Centre for Menstrual Cycle and Ovulation Research

I just read “The Estrogen Dilemma” in Sunday’s New York Times Magazine,  and I feel like weeping—in sorrow and deep sadness. This article by Cynthia Gorney is about energetic, intelligent women who feel they must take estrogen in order to survive perimenopause yet have deep worries about its risks. I know personally the anguishing changes that erupt during perimenopause. “The Estrogen Dilemma” also evoked my frustration and even rage. It is wrong that symptomatic women in the midst of the long and stormy midlife transition have to face a conundrum—to take estrogen or not. It arises from a Nixonian-style cover-up of three proven and important-for-women truths: 1)    Perimenopause causes higher and not lower estrogen levels. (By perimenopause I mean the transition from fertile menstrual cycles to menopause, or the life phase beginning one year beyond the final menstrual flow.) 2)    Progesterone, estrogen’s essential partner hormone, in contrast to estrogen, truly is lower in perimenopause. 3)    Women survive perimenopause and “graduate” into a less symptomatic menopause.

Readers should note that statements published in re: Cycling are those of individual authors and do not necessarily reflect the positions of the Society as a whole.